| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80048 |
Basic metabolic panel (calcium, ionized) |
154 |
152 |
$0.00 |
| 83735 |
|
365 |
343 |
$0.00 |
| 82043 |
|
287 |
279 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
716 |
713 |
$0.00 |
| 3075F |
|
216 |
207 |
$0.00 |
| 86706 |
|
303 |
303 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,531 |
1,518 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
871 |
857 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,916 |
1,692 |
$0.00 |
| 90686 |
|
95 |
95 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
453 |
452 |
$0.00 |
| 82746 |
|
257 |
255 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,228 |
2,791 |
$0.00 |
| 81001 |
|
180 |
170 |
$0.00 |
| 86780 |
|
345 |
343 |
$0.00 |
| 3044F |
|
389 |
388 |
$0.00 |
| 99441 |
|
77 |
75 |
$0.00 |
| 87340 |
|
300 |
299 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,369 |
1,202 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
669 |
665 |
$0.00 |
| 83550 |
|
83 |
82 |
$0.00 |
| 1220F |
|
595 |
594 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
63 |
62 |
$0.00 |
| 82607 |
|
440 |
439 |
$0.00 |
| 3074F |
|
888 |
819 |
$0.00 |
| 85027 |
|
442 |
422 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
80 |
79 |
$0.00 |
| 82728 |
|
110 |
109 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
612 |
599 |
$0.00 |
| 1111F |
|
337 |
318 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
95 |
93 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
123 |
110 |
$0.00 |
| 3079F |
|
148 |
143 |
$0.00 |
| 90656 |
|
75 |
75 |
$0.00 |
| 4450F |
|
45 |
45 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
15 |
$0.00 |
| 90739 |
|
12 |
12 |
$0.00 |
| 85652 |
|
13 |
13 |
$0.00 |
| 99386 |
|
15 |
15 |
$0.00 |
| 99385 |
|
12 |
12 |
$0.00 |
| 86140 |
|
14 |
14 |
$0.00 |
| 82274 |
|
295 |
295 |
$0.00 |
| 3078F |
|
1,077 |
978 |
$0.00 |
| 86703 |
|
466 |
463 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,064 |
874 |
$0.00 |
| 82540 |
|
287 |
279 |
$0.00 |
| 80061 |
Lipid panel |
1,330 |
1,323 |
$0.00 |
| 99442 |
|
468 |
457 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
1,584 |
1,567 |
$0.00 |
| 84439 |
|
40 |
39 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
55 |
55 |
$0.00 |
| 81003 |
|
47 |
41 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
252 |
143 |
$0.00 |
| 83540 |
|
101 |
100 |
$0.00 |
| 85610 |
|
77 |
67 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
25 |
25 |
$0.00 |
| 3077F |
|
166 |
152 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
141 |
140 |
$0.00 |
| 2021F |
|
12 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
63 |
62 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
13 |
13 |
$0.00 |
| 90750 |
|
41 |
41 |
$0.00 |
| 84100 |
|
28 |
24 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
13 |
$0.00 |
| 3051F |
|
12 |
12 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15 |
15 |
$0.00 |